O'Dowd Sarah A

CIK 00014471493 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001447149

Recent Transactions

50 trades

Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 7,825 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 5,130 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2024-05-15+3,923→ 28,325 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2023-05-18+4,752→ 24,402 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2023-01-16+30,000→ 30,000 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2022-05-24+5,635→ 19,650 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2021-05-11+2,526→ 14,015 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2020-08-17+30,000→ 30,000 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2020-05-12+4,596→ 11,489 total
Award
ICHOR HOLDINGS, LTD.$ICHR
Ordinary Shares, par value $0.0001
2020-05-12+6,893→ 6,893 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2019-12-19$287.80/sh−3,831→ 32,084 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Common Stock
2019-09-11$42.61/sh+22,140→ 58,007 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Employee Stock Option (Right to Buy)
2019-09-11$42.61/sh−22,140→ 0 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2019-09-11$233.77/sh−22,140→ 35,867 total
Gift
LAM RESEARCH CORP$LRCX
Common Stock
2019-09-06−3,646→ 35,867 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2019-09-06$229.07/sh−5,000→ 39,513 total
Award
LAM RESEARCH CORP$LRCX
Employee Stock Option (Right to Buy)
2019-03-01$176.75/sh+5,948→ 5,948 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2019-03-01$176.75/sh−486→ 42,167 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2019-03-01$176.75/sh−1,004→ 43,452 total
Award
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2019-03-01+3,717→ 3,717 total
Award
LAM RESEARCH CORP$LRCX
Common Stock
2019-03-01+2,230→ 44,397 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2019-03-01$176.75/sh−4,733→ 44,456 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2019-03-01$176.75/sh−799→ 42,653 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Common Stock
2019-02-11+11,233→ 49,189 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2019-02-11+10,127→ 0 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2018-03-22$224.28/sh−10,000→ 37,832 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2018-03-08$212.64/sh−1,835→ 47,832 total
Award
LAM RESEARCH CORP$LRCX
Employee Stock Option (Right to Buy)
2018-03-01$190.07/sh+2,944→ 2,944 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2018-03-01$190.07/sh−798→ 46,720 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2018-03-01$190.07/sh−1,003→ 47,518 total
Award
LAM RESEARCH CORP$LRCX
Common Stock
2018-03-01+2,947→ 49,667 total
Award
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2018-03-01+3,684→ 3,684 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2018-02-09+8,064→ 0 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2018-02-09$165.87/sh−1,066→ 48,521 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2018-02-09$165.87/sh−5,114→ 49,587 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Common Stock
2018-02-09$165.87/sh+12,096→ 54,701 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2017-06-22$150.92/sh−10,000→ 42,517 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2017-03-07$118.61/sh−2,481→ 52,341 total
Sale
LAM RESEARCH CORP$LRCX
Common Stock
2017-03-06$117.07/sh−3,978→ 54,822 total
Award
LAM RESEARCH CORP$LRCX
Common Stock
2017-03-01+4,835→ 58,800 total
Award
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2017-03-01+6,044→ 24,235 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2017-03-01$119.67/sh−1,056→ 53,965 total
Award
LAM RESEARCH CORP$LRCX
Employee Stock Option (Right to Buy)
2017-03-01+4,832→ 55,256 total
Tax Payment
LAM RESEARCH CORP$LRCX
Common Stock
2017-02-24$114.90/sh−9,363→ 55,021 total
Exercise/Conversion
LAM RESEARCH CORP$LRCX
Market-based Performance Restricted Stock Unit
2017-02-17−12,557→ 0 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov